Real-time non-invasive bilirubin monitoring system for newborns based on near-infrared spectroscopy
By using a non-invasive monitoring system based on near-infrared spectroscopy, combined with multi-wavelength sensors and the PLSR algorithm, non-invasive, real-time, and continuous high-precision monitoring of neonatal bilirubin has been achieved. This solves the problems of pain, large errors, and cross-infection associated with existing technologies, and improves monitoring efficiency and safety.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- ZHEJIANG XIAOSHAN HOSPITAL
- Filing Date
- 2026-04-15
- Publication Date
- 2026-07-24
AI Technical Summary
Current neonatal bilirubin monitoring technologies cannot achieve non-invasive, real-time, and continuous high-precision monitoring. They are painful, have large errors, are inconvenient, and pose a risk of cross-infection, making it difficult to meet the clinical need for continuous monitoring of neonatal jaundice.
A non-invasive monitoring system based on near-infrared spectroscopy is adopted, including a multi-wavelength near-infrared sensor module, a signal acquisition and preprocessing module, a control and processing module, a wireless communication module, and a power supply module. Combined with the PLSR algorithm and low-power design, it realizes real-time wireless transmission of bilirubin concentration and personalized early warning.
It achieves non-invasive, real-time, and continuous high-precision bilirubin monitoring, reducing the measurement error to ±0.5 mg/dl, lowering the risk of kernicterus, improving medical efficiency and parental satisfaction, and meeting infection control requirements.
Smart Images

Figure CN122440184A_ABST